NHS National Framework for Transition Products (Nintedanib and Dalbavancin)

Open

Buyers

Value

£115,756,000

Classifications

  • Pharmaceutical products

Tags

  • tender

Submission Deadline

1 month from now

Published

23 hours ago

Description

Project title: NHS National Framework for Transition Products (Nintedanib and Dalbavancin) commencing 1st May 2026
Offer reference number: CM/TNS/25/5736
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months.
CM/TNS/25/5736 Nintedanib and Dalbavancin 
Lot 1 DLN/DNW: 01/05/2026 to 30/09/2027 (17 months)
Lot 2 DLS/DNE: 01/05/2026 to 31/05/2027 (13 months) 
Lot 3 DCE/DSW: 01/05/2026 to 31/01/2027 (9 months)
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Similar Contracts

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Timeline active

Publish
Bid
Evaluate
Award
Complete